Royal Bank Of Canada Issues Pessimistic Forecast for HealthEquity (NASDAQ:HQY) Stock Price

HealthEquity (NASDAQ:HQY) had its target price dropped by stock analysts at Royal Bank Of Canada from $110.00 to $100.00 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank Of Canada’s target price suggests a potential upside of 23.26% from the company’s previous close.

Other analysts also recently issued reports about the stock. Citizens Jmp set a $122.00 price objective on shares of HealthEquity in a report on Thursday, December 4th. Barrington Research reissued an “outperform” rating and set a $125.00 target price on shares of HealthEquity in a research report on Thursday, December 4th. Barclays decreased their price target on shares of HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a report on Wednesday, February 18th. Jefferies Financial Group set a $108.00 price target on HealthEquity in a research report on Thursday, February 19th. Finally, Raymond James Financial set a $100.00 price objective on HealthEquity in a research note on Tuesday, February 17th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, HealthEquity presently has a consensus rating of “Moderate Buy” and a consensus price target of $110.36.

HealthEquity Price Performance

HQY opened at $81.13 on Wednesday. The stock has a fifty day moving average of $80.59 and a 200-day moving average of $90.13. The firm has a market capitalization of $6.85 billion, a P/E ratio of 32.98, a PEG ratio of 0.99 and a beta of 0.26. HealthEquity has a 12-month low of $72.76 and a 12-month high of $116.65. The company has a quick ratio of 4.13, a current ratio of 3.27 and a debt-to-equity ratio of 0.45.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.05. HealthEquity had a return on equity of 13.86% and a net margin of 16.39%.The firm had revenue of $334.59 million during the quarter, compared to analyst estimates of $332.48 million. The firm’s revenue for the quarter was up 7.3% on a year-over-year basis. Equities analysts forecast that HealthEquity will post 2.32 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in HQY. Acumen Wealth Advisors LLC acquired a new stake in HealthEquity during the fourth quarter worth about $27,000. Caitong International Asset Management Co. Ltd raised its holdings in HealthEquity by 1,723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after acquiring an additional 293 shares in the last quarter. Aster Capital Management DIFC Ltd bought a new stake in shares of HealthEquity in the 4th quarter worth approximately $28,000. True Wealth Design LLC grew its holdings in shares of HealthEquity by 3,522.2% during the 3rd quarter. True Wealth Design LLC now owns 326 shares of the company’s stock worth $31,000 after purchasing an additional 317 shares in the last quarter. Finally, Farther Finance Advisors LLC grew its holdings in shares of HealthEquity by 59.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock worth $37,000 after purchasing an additional 146 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity News Roundup

Here are the key news stories impacting HealthEquity this week:

• Positive Sentiment: Deutsche Bank raised its price target to $128 and kept a “buy” rating — the new target implies ~57.8% upside from the current price, signaling strong analyst conviction. Deutsche Bank price target raise
• Positive Sentiment: Q4 2026 results and call highlighted record HSA growth, revenue and EPS beats (quarterly revenue and EPS modestly ahead of consensus), supporting continued top-line momentum and cash economics. HQY Q4 2026 Earnings Call Highlights
• Positive Sentiment: Seeking Alpha published a rating upgrade citing improved cash economics, which reinforces buy-side theses around margin expansion and free cash flow improvement. Seeking Alpha upgrade
• Positive Sentiment: Press roundup / analyst commentary piece flagged HealthEquity among bullish healthcare names, adding to positive market narrative. Globe & Mail analyst roundup
• Neutral Sentiment: Full Q4 earnings call transcripts were posted across outlets (MSN, Seeking Alpha, Yahoo) — useful for digging into management commentary on enrollment, revenue cadence and margin drivers but not new information beyond the released results. MSN earnings transcript Seeking Alpha earnings transcript
• Negative Sentiment: Barrington Research trimmed its price target from $125 to $110 (still “outperform”), reducing upside assumptions to ~35.6% and signaling slightly less bullishness from one coverage shop. Barrington price target update
• Negative Sentiment: JPMorgan lowered its target from $129 to $123 but maintained an “overweight” rating, trimming some upside expectations while staying constructive (~51.6% implied upside). JPMorgan price target update
• Negative Sentiment: RBC cut its target from $110 to $100 (still “outperform”), tightening the analyst target band and signaling a more cautious near-term view. RBC price target update

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.